Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome. Julien Zuber , Marie Frimat , Sophie Caillard , Nassim Kamar , Philippe Gatault , Florent Petitprez , Lionel Couzi , Noemie Jourde-Chiche , Valerie Chatelet , Raphael Gaisne , Dominique Bertrand , Jamal Bamoulid , Magali Louis , Rebecca Sberro Soussan , David Navarro , Pierre-Francois Westeel , Luc Frimat , Charlotte Colosio , Antoine Thierry , Joseph Rivalan , Laetitia Albano , Nadia Arzouk , Emilie Cornec-Le Gall , Guillaume Claisse , Michelle Elias , Khalil El Karoui , Sophie Chauvet , Jean-Philippe Coindre , Jean-Philippe Rerolle , Leila Tricot , Johnny Sayegh , Cyril Garrouste , Christophe Charasse , Yahsou Delmas , Ziad Massy , Maryvonne Hourmant , Aude Servais , Chantal Loirat , Fadi Fakhouri , Claire Pouteil-Noble , Marie-Noelle Peraldi , Christophe Legendre , Eric Rondeau , Moglie Le Quintrec , Veronique Fremeaux-Bacchi JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY（2019）
关键词
complement, hemolytic uremic syndrome, kidney transplantation
AI 理解论文
溯源树
样例
